TerminatedPhase 3NCT02759120
CleanUP IPF for the Pulmonary Trials Cooperative
Studying Idiopathic pulmonary fibrosis
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Weill Medical College of Cornell University
- Principal Investigator
- Fernando Martinez, MD, MSWeill Cornell Medical Medicine
- Intervention
- Antimicrobial therapy: Co-trimoxazole or Doxycycline(drug)
- Enrollment
- 513 enrolled
- Eligibility
- 40 years · All sexes
- Timeline
- 2017 – 2020
Study locations (30)
- University of Alabama at Birmingham, Birmingham, Alabama, United States
- University of Arizona, Tucson, Arizona, United States
- University of California Davis Medical Center, Sacramento, California, United States
- Stanford, Stanford, California, United States
- Loyola University Chicago, Chicago, Illinois, United States
- Northwestern University, Chicago, Illinois, United States
- University of Chicago, Chicago, Illinois, United States
- University of Kansas, Kansas City, Kansas, United States
- Massachusetts General Hospital, Boston, Massachusetts, United States
- Brigham and Women's Hospital, Boston, Massachusetts, United States
- Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States
- University of Michigan, Ann Arbor, Michigan, United States
- Spectrum Health, Grand Rapids, Michigan, United States
- University of Minnesota, Minneapolis, Minnesota, United States
- Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire, United States
- +15 more locations on ClinicalTrials.gov
Collaborators
Duke Clinical Research Institute · University of Chicago · University of Washington · University of Pittsburgh · National Heart, Lung, and Blood Institute (NHLBI)
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT02759120 on ClinicalTrials.govOther trials for Idiopathic pulmonary fibrosis
Additional recruiting or active studies for the same condition.
- RECRUITINGPHASE1NCT05988463Dose-Escalation Study of Artesunate Patients With IPFJoseph C. Wu
- RECRUITINGNANCT07486206Optimizing the Follow-Up Journey in Interstitial Lung Disease: The OPTIMIZE-ILD-2 TrialHospital de Granollers
- RECRUITINGNANCT07482917Optimizing the Diagnostic Journey in Interstitial Lung Disease: The OPTIMIZE-ILD-1 TrialHospital de Granollers
- RECRUITINGPHASE2NCT06241560A Study in People With Idiopathic Pulmonary Fibrosis to Test Whether Pirfenidone Influences the Amount of BI 1015550 in the BloodBoehringer Ingelheim
- RECRUITINGPHASE3NCT07201922A Study to Test Whether Nerandomilast Can Help Slow Down Changes in the Lung in People With a Family History of Pulmonary FibrosisBoehringer Ingelheim
- RECRUITINGNANCT07466420Study on the Efficacy of Quercetin Intake in Patients With Fibrotic Interstitial Lung Diseases.Katerina M. Antoniou
- RECRUITINGPHASE3NCT07299695Intravenous Immunoglobulin for the Treatment of Acute Exacerbations of Idiopathic Pulmonary FibrosisArgyrios Tzouvelekis
- RECRUITINGPHASE2NCT07284459Study to Evaluate the Efficacy, Safety, and Tolerability of PIPE 791 in Subjects With Idiopathic Pulmonary FibrosisContineum Therapeutics